ARCHIVES

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

This article is from The Cancer Letter archive.

Vol. 39 No. 18 | May 8, 2013

Download PDF Visit The Full Archive

Related Articles

Oncologist Pans Breast Cancer Conference In Russian Heartland

August 19, 1994

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

March 17, 1995

NIH Advisors Urge Stronger Peer Review, Clinical Center Renewal

May 20, 1994

In Brief: Congress Recesses With No More Action On Waxman Bill; BCTF to Look at New Diagnosis, Detection

August 12, 1983

In Brief: ACOS Moves Up Schedule for TNM Staging System From 1986 To “As Expeditiously As Possible”

January 13, 1984